Announced details
Anti-fibrotic activity; fibrotic mechanisms and novel therapeutic targets
Research partner that jointly analyzed the pharmacological effects of SMTP compounds.
The Division of Respiratory Medicine and Rheumatology, Tokushima University Graduate School of Biomedical Sciences. Location, representative, capital, year established and other information are Not disclosed.
Station Conference Tokyo (Sapia Tower, 4th–6th floors, 1-7-12 Marunouchi, Chiyoda-ku, Tokyo)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
1st Annual Meeting of the Japanese Society of Diffuse Lung Diseases
| Item | Details |
|---|---|
| Names of Products / Services Covered | SMTP-44D (novel soluble epoxide hydrolase inhibitor) |
| Counterparty | Division of Respiratory Medicine and Rheumatology, Tokushima University Graduate School of Biomedical Sciences |
| Counterparty overview | The Division of Respiratory Medicine and Rheumatology, Tokushima University Graduate School of Biomedical Sciences. Location, representative, capital, year established and other information are Not disclosed. |
| Relationship with the Company | Research partner that jointly analyzed the pharmacological effects of SMTP compounds. |
| Launch date | Conference presentation scheduled for 20 September 2026 (Sunday), 16:05–16:40 |
| Applicable area | Anti-fibrotic activity; fibrotic mechanisms and novel therapeutic targets |
| Location | Station Conference Tokyo (Sapia Tower, 4th–6th floors, 1-7-12 Marunouchi, Chiyoda-ku, Tokyo) |
| Source | 1st Annual Meeting of the Japanese Society of Diffuse Lung Diseases |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To present the results of the joint research at the 1st Annual Meeting of the Japanese Society of Diffuse Lung Diseases.